Nonkeratinizing Nasopharyngeal Carcinoma, Undifferentiated Type With Trisomy 2: A Case Report and Short Review of Cytogenetic and Molecular Literature.

Carcinoma originating from the surface epithelium of the nasopharynx is classified by the World Health Organization (WHO) as nasopharyngeal carcinoma (NPC) and has 3 main types: keratinizing squamous cell carcinoma (WHO type 1) and nonkeratinizing carcinoma, differentiated (WHO type II), and undifferentiated (WHO type III). Nonkeratinizing NPC is strongly associated with prior Epstein-Barr virus (EBV) infection. These tumors may be divided into differentiated and undifferentiated carcinoma.

DNA and carbon nanotubes as medicine.

The identification of disease-related genes and their complete nucleotide sequence through the human genome project provides us with a remarkable opportunity to combat a large number of diseases with designed genes as medicine. However, gene therapy relies on the efficient and nontoxic transport of therapeutic genetic medicine through the cell membranes, and this process is very inefficient. Carbon nanotubes, due to their large surface areas, unique surface properties, and needle-like shape, can deliver a large amount of therapeutic agents, including DNA and siRNAs, to the target disease sites.

Improved conductivity of carbon nanotube networks by in situ polymerization of a thin skin of conducting polymer.

The overall conductivity of SWNT networks is dominated by the existence of high resistance and tunneling/Schottky barriers at the intertube junctions in the network. Here we report that in situ polymerization of a highly conductive self-doped conducting polymer "skin" around and along single stranded DNA dispersed and functionalized single wall carbon nanotubes can greatly decrease the contact resistance. The polymer skin also acts as "conductive glue" effectively assembling the SWNTs into a conductive network, which decreases the amount of SWNTs needed to reach the high conductive regime of the network.